Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

LANSOPRAZOLE Drug Profile

« Back to Dashboard

Which patents cover Lansoprazole, and what generic Lansoprazole alternatives are available?

Lansoprazole is a drug marketed by Labs Liconsa, Natco Pharma Ltd, Sun Pharm Inds Ltd, Krka Tovarna Zdravil, Perrigo R And D, Dexcel Pharma, Wockhardt Ltd, Ani Pharms Inc, Sandoz, Teva Pharms, Ajanta Pharma Ltd, Mylan Pharms Inc, Zydus Hlthcare, Dr Reddys Labs Ltd, Wockhardt Usa, Rising Pharms Inc, Teva Pharms Usa, and Sandoz Inc. and is included in twenty-two NDAs.

The generic ingredient in LANSOPRAZOLE is amoxicillin; clarithromycin; lansoprazole. There are forty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.

Summary for Tradename: LANSOPRAZOLE

Patents:0
Applicants:18
NDAs:22
Suppliers / Packagers: see list82
Bulk Api Vendors: see list81
Clinical Trials: see list47
Patent Applications: see list3,852
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LANSOPRAZOLE at DailyMed

Pharmacology for Tradename: LANSOPRAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN
amoxicillin; clarithromycin; lansoprazole
CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL200218-001Aug 30, 2013ABRXNoNo► Subscribe► Subscribe
Wockhardt Usa
LANSOPRAZOLE
lansoprazole
CAPSULE, DELAYED REL PELLETS;ORAL202176-002Sep 14, 2012ABRXNoNo► Subscribe► Subscribe
Sandoz Inc
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN
amoxicillin; clarithromycin; lansoprazole
CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL202588-001Mar 4, 2014ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
LANSOPRAZOLE
lansoprazole
CAPSULE, DELAYED REL PELLETS;ORAL203187-001Jun 1, 2016OTCNoNo► Subscribe► Subscribe
Labs Liconsa
LANSOPRAZOLE
lansoprazole
CAPSULE, DELAYED REL PELLETS;ORAL203203-001Jul 25, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot